High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples

Authors

  • Adrian A. Pater Southern Illinois University
  • Michael S. Bosmeny Southern Illinois University
  • Adam A. White Southern Illinois University
  • Rourke J. Sylvain Southern Illinois University
  • Seth B. Eddington Southern Illinois University
  • Mansi Parasrampuria Southern Illinois University
  • Katy N. Ovington Southern Illinois University
  • Paige E. Metz Southern Illinois University
  • Abadat O. Yinusa Southern Illinois University
  • Christopher L. Barkau Southern Illinois University
  • Ramadevi Chilamkurthy Southern Illinois University
  • Scott W. Benzinger Southern Illinois University
  • Madison M. Hebert Southern Illinois University
  • Keith T. Gagnon School of Medicine Chemistry and Biochemistry Southern Illinois University

Keywords:

SARS-CoV-2, sequencing, nanopore, MinION, COVID-19, genome, mutations, protocol

Abstract

In late 2019, a novel coronavirus began spreading in Wuhan, China, causing a potentially lethal respiratory viral infection. By early 2020, the novel coronavirus, called SARS-CoV-2, had spread globally, causing the COVID-19 pandemic. The infection and mutation rates of SARS-CoV-2 make it amenable to tracking introduction, spread and evolution by viral genome sequencing. Efforts to develop effective public health policies, therapeutics, or vaccines to treat or prevent COVID-19 are also expected to benefit from tracking mutations of the SARS-CoV-2 virus. Here we describe a set of comprehensive working protocols, from viral RNA extraction to analysis using established visualization tools, for high throughput sequencing of SARS-CoV-2 viral genomes using a MinION instrument. This set of protocols should serve as a reliable "how-to" reference for generating quality SARS-CoV-2 genome sequences with ARTIC primer sets and long-read nanopore sequencing technology. In addition, many of the preparation, quality control, and analysis steps will be generally applicable to other sequencing platforms.

References

Daszak P, Keusch GT, Phelan AL, Johnson CK, Osterholm MT. Infectious Disease Threats: A Rebound To Resilience. Health Aff (Millwood). 2021 Feb;40(2):204–11. https://doi.org/10.1377/hlthaff.2020.01544 PMID:33476187

Grubaugh ND, Hodcroft EB, Fauver JR, Phelan AL, Cevik M. Public health actions to control new SARS-CoV-2 variants. Cell. 2021 Mar;184(5):1127–32.https://doi.org/10.1016/j.cell.2021.01.044 PMID:33581746

Gardy J, Loman NJ, Rambaut A. Real-time digital pathogen surveillance - the time is now. Genome Biol. 2015 Jul;16(1):155. https://doi.org/10.1186/s13059-015-0726-x PMID:27391693

Khudyakov Y. Molecular surveillance of hepatitis C. Antivir Ther. 2012;17 (7 Pt B):1465–70. https://doi.org/10.3851/IMP2476 PMID:23321496

McGinnis J, Laplante J, Shudt M, George KS. Next generation sequencing for whole genome analysis and surveillance of influenza A viruses. J Clin Virol. 2016 Jun;79:44-50. https://doi.org/10.1016/j.jcv.2016.03.005 PMID: 27085509

Houldcroft CJ, Beale MA, Breuer J. Clinical and biological insights from viral genome sequencing. Nat Rev Microbiol. 2017 Mar;15(3):183–92. https://doi.org/10.1038/nrmicro.2016.182 PMID:28090077

Thomson E, Ip CL, Badhan A, Christiansen MT, Adamson W, Ansari MA, et al. Comparison of Next-Generation Sequencing Technologies for Comprehensive Assessment of Full-Length Hepatitis C Viral Genomes. J Clin Microbiol. 2016 Oct;54(10):2470–84. https://doi.org/10.1128/JCM.00330-16 PMID:27385709

Quick J, Grubaugh ND, Pullan ST, Claro IM, Smith AD, Gangavarapu K, et al. Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples. Nat Protoc. 2017 Jun;12(6):1261–76. https://doi.org/10.1038/nprot.2017.066 PMID:28538739

Tyson JR, et al. Improvements to the ARTIC multiplex PCR method for SARS-CoV-2 genome sequencing using nanopore. bioRxiv : the preprint server for biology, (Sep 4, 2020).

Bull RA, Adikari TN, Ferguson JM, Hammond JM, Stevanovski I, Beukers AG, et al. Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis. Nat Commun. 2020 Dec;11(1):6272. https://doi.org/10.1038/s41467-020-20075-6 PMID:33298935

Baker DJ, Aydin A, Le-Viet T, Kay GL, Rudder S, de Oliveira Martins L, et al. CoronaHiT: high-throughput sequencing of SARS-CoV-2 genomes. Genome Med. 2021 Feb;13(1):21. https://doi.org/10.1186/s13073-021-00839-5 PMID:33563320

Gohl DM, Garbe J, Grady P, Daniel J, Watson RH, Auch B, et al. A rapid, cost-effective tailed amplicon method for sequencing SARS-CoV-2. BMC Genomics. 2020 Dec;21(1):863. https://doi.org/10.1186/s12864-020-07283-6 PMID:33276717

Li J, Wang H, Mao L, Yu H, Yu X, Sun Z, et al. Rapid genomic characterization of SARS-CoV-2 viruses from clinical specimens using nanopore sequencing. Sci Rep. 2020 Oct;10(1):17492. https://doi.org/10.1038/s41598-020-74656-y PMID:33060796

Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT, Ruis C, et al. A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology. Nat Microbiol. 2020 Nov;5(11):1403–7. https://doi.org/10.1038/s41564-020-0770-5 PMID:32669681

Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018 Dec;34(23):4121–3. https://doi.org/10.1093/bioinformatics/bty407 PMID:29790939

Pastorino B, Touret F, Gilles M, Luciani L, de Lamballerie X, Charrel RN. Evaluation of Chemical Protocols for Inactivating SARS-CoV-2 Infectious Samples. Viruses. 2020 Jun;12(6):624. https://doi.org/10.3390/v12060624 PMID:32521706

Itokawa K, Sekizuka T, Hashino M, Tanaka R, Kuroda M. Disentangling primer interactions improves SARS-CoV-2 genome sequencing by multiplex tiling PCR. PLoS One. 2020 Sep;15(9):e0239403. https://doi.org/10.1371/journal.pone.0239403 PMID:32946527

Potapov V, Ong JL. Examining Sources of Error in PCR by Single-Molecule Sequencing. PLoS One. 2017 Jan;12(1):e0169774. https://doi.org/10.1371/journal.pone.0169774 PMID:28060945

Singer J, Gifford R, Cotten M, Robertson D. CoV-GLUE: A Web Application for Tracking SARS-CoV-2 Genomic Variation. Preprints. 18 Jun 2020. https://doi.org/10.20944/preprints202006.0225.v1

Graphical_abstract

Downloads

Additional Files

Published

2021-09-27

How to Cite

1.
Pater AA, Bosmeny MS, White AA, Sylvain RJ, Eddington SB, Parasrampuria M, Ovington KN, Metz PE, Yinusa AO, Barkau CL, Chilamkurthy R, Benzinger SW, Hebert MM, Gagnon KT. High throughput nanopore sequencing of SARS-CoV-2 viral genomes from patient samples. J Biol Methods [Internet]. 2021Sep.27 [cited 2021Dec.4];8(COVID 19 Special Issue):e155. Available from: https://jbmethods.org/jbm/article/view/360

Issue

Vol. 8 No. COVID 19 Special Issue (2021)

Section

Articles

License

Copyright (c) 2021 Adrian A. Pater, Michael S. Bosmeny, Adam A. White, Rourke J. Sylvain, Seth B. Eddington, Mansi Parasrampuria, Katy N. Ovington, Paige E. Metz, Abadat O. Yinusa, Christopher L. Barkau, Ramadevi Chilamkurthy, Scott W. Benzinger, Madison M. Hebert, Keith T. Gagnon

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Authors who publish with JBM agree to the following terms:

  1. Authors retain copyright and grant JBM right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).